A new survey points to a hard money choice for some Americans: paying for Ozempic or putting that cash toward retirement. NewsNation has the numbers.
Recap by typeshit. Full story at NewsNation.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
TheStreet looks at what that means for patients paying up to $1,500 a month for peptide therapy and how the ruling could affect what they pay.
Novo Nordisk's newest Wegovy injection puts fresh pressure on rivals in the race to lead obesity treatment, The Times reports.
Loading…